Documente Academic
Documente Profesional
Documente Cultură
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
2
4. The drug illustrated below:
NH2
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
3
8. The drug illustrated below:
N CH3
H2C
N O I is a mitotic spindle poison.
O
O
N II is a substrate for the efflux transporters MDR1 and BCRP.
N
III stabilizes the cleaved complex formed from topoisomerase I and DNA.
O
H3CH2C
OH O
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
9. The drug illustrated below:
NH2
N
N
I inhibits dihydrofolate reductase in bacteria.
H2C NH2
II irreversibly inhibits the enzyme thymidylate synthetase.
OCH3 III blocks protein synthesis by binding to ribosomal RNA.
H3CO OCH3
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
N N
N I is used in monotherapy (single-agent therapy) of HIV infection.
II is NOT cross-resistant with nucleoside reverse transcriptase inhibitors.
N III is a non-competitive inhibitor of reverse transcriptase.
CH3
O H
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
4
12. The drug illustrated below:
I is leucovorin and is used in “rescue therapy”.
II inhibits DNA synthesis by limiting the DeNovo synthesis
of thymidine.
III inhibits dihydofolate reductase.
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
O CH3
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
H
C CH I is an oral contraceptive.
II is an estrogenic steroid.
H H III has a 11β-hydroxyl group.
HO
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
6
20. The drug illustrated below:
O
HN F I is converted to its 2’-deoxyribosylmonophosphate.
O II ultimately can irreversibly bind to and inhibit thymidylate synthetase.
N III is associated with photosensitivity.
H
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
CH OH
OH 2 I acts by targeting topoisomerase II.
OCH3O OH
II is known to exhibit cardiac toxicity.
O
III extravasation of this agent is associated with severe
H3C
O necrosis at the site of infusion.
NH2
OH
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
8
28. The drug illustrated below:
O
HN N
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
9
32. The drug illustrated below is:
HO O
S CH3 I a highly effective Gram (-) antibiotic.
N C N
N
N
II orally active.
O H2 III a β-lactamase inhibitor.
COOH
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
33.
Bevacizumab, is an antibody that binds to the receptor for vascular
I
Avastin® endothelial growth factor.
II is a humanized monoclonal antibody.
III prevents the vascularization (endothelial cell growth) that is
associated with tumor growth
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
34. The drug illustrated below:
HO
CH 2CH3
38.
Acute
I is uncontrolled growth of B- or T-lymphocytes.
Lymphocytic
II is the most common of childhood leukemia
Leukemia (ALL)
III is the uncontrolled growth of granulocytes.
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
O
I Is a potent glucocorticoid.
CH3
HO O II Is a potent mineralocorticoid.
CH3 H
O III Is used as an abortifacient.
F H
O
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
43. The drug illustrated below:
Rituximab, I is a monoclonal antibody used to treat metastatic breast cancers that
Rutuxin® overexpresses human epidermal growth factor 2, HER2.
II acts as an antiangiogenic agent to prevent the production of new blood vessels.
III is used in the treatment of non-Hodgkin’s lymphoma that possess the
membrane bound phosphoprotein, CD-20.
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
12
44. The drug illustrated below is:
O I converted to its disulfide in the kidney and then rapidly eliminated in urine.
HS CH2 CH2 S O II used to prevent hemorrhagic cystitis that is commonly associated with the
O Na administration of cyclophosphoramide.
III rapidly converted to its disulfide in the bloodstream.
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
49. The drug illustrated below:
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
a I only
b III only
c I and II only
d II and III only
e I, II, and III Answer
Part 2 Generic Names (9 Points). Provide the Generic Names for the Compounds listed on
the following page. In the space provided under the structure of each the compounds
illustrated, write the correct CAPITALIZED letter corresponding to the choice of answers
given on the bottom of the page. The letter “Z” may be used as an answer as seldom or as
often as needed.
14
O CH3 OH
F CO2H
H3CO OCH3
O CH3 H
N N
H2N S N N
N O CH3 H H
O H N H3C H O
Answer Answer Answer
HO O
H CH3 H H N(CH3)2 H
CH3
H O CH3
OH H3C H H CH3 N HN N CH2 C
N
O
HO H H CH3
NH2 H N
H S O H
OH N N
OH O OH O O O H O
COOH
Answer Answer
Answer
H2N
N O
H3C CH3 O H H
O S
H S N S
H3C N N N O
N N H O
OH H N N N
H3C S CH3 H O
OCH3O CH2OCCH3
CO2
Na
Answer Answer
Answer
6'
H2NH2C
O
H2N
HO
NH2 NH2
O
O
HO
HOCH2
O
HO OH
H2N
Answer
Answer Answer
H O
CH3 H H
CH3 H2N C N S CH3
N C C C CH3 H
CH3 N CH3
O
COOH
HO
Answer Answer Answer
N O CH3
N H CH3 N
N H 3C
N
OH CH3 CH3 OH
O N C C CH 3
F F O H
HO
N H
N N3 O
F
Answer Answer
Answer
A. Cefotaxime J. Mifepristone S. Dacarbazine
B. Etoposide K. Testosterone T. Dexrazone
C. Clavulanic acid L. Amoxicillin U. Aldosterone
D. Doxycycline M. Zidovudine V. Piperacillin
E. Betamethazone N. Finasteride W. Levofloxacin
F. Topotecan O. Meropenem X. Ritonavir
G. Tobramycin P. Trimethoprim Y. Voriconazole
H. Terbinafine Q. Ribavirin Z. None of These
I. Sulfadoxine R. Oseltamivir
15
Part 3 Nomenclature 16 Points.
When using the basic templates provided insert all unsaturation as required and specify the
orientation of all functionality or hydrogen atoms by using BOLD lines/wedges or HASHED
lines/wedges.
Example
H3C
CH3 CH3
OR NOT
H H H
1. Pregna-1,4-diene-3,20-dione, 11β-hydroxy-6α-methyl
[known as Endrysone]
Exam Total:
Part 1. Multiple Choice 75 Points
Total